Dana-Farber/Brigham and Women's Cancer Center at South Shore is a clinical research site located in South Weymouth, Massachusetts, United States 02190.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Dana-Farber/Brigham and Women's Cancer Center at South Shore has participated in 46 clinical trials with 29 currently active.
Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber/Brigham and Women's Cancer Center at South Shore has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber/Brigham and Women's Cancer Center at South Shore has 46 clinical trials on record, with 29 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Yes — Dana-Farber/Brigham and Women's Cancer Center at South Shore holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.